Day: November 29, 2023

Form 8.3 – [Young & Co.’s Brewery plc – 28 11 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date...

Continue reading

Form 8.3 – [abrdn European Logistics Income Limited – 28 11 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree abrdn EUROPEAN LOGISTICS INCOME PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date...

Continue reading

Further Partial Withdrawal of Letter of Intent – DX (Group) plc – 28 11 2023 (CGAML)

Letter of Intent: Acquisition of DX (Group) plc by Transit Bidco Limited On 15th November 2023, Canaccord Genuity Asset Management Limited provided a Letter of Intent regarding our intentions in relation to 80,000,0000 shares. In accordance with The City Code on Takeovers and Mergers, Rule 2.10 (c)(i), we advise that we have disposed of a further 9,000,000 shares, following on from our disposal of 31,000,000 on 27th November 2023. Consequently, we are no longer able to accept or procure the acceptance of the Offer, in relation to any of the shares disposed of. Our intention in respect of the remaining 40,000,000 shares is now as described in the original Letter of Intent. Mark ElliottInvestment Controls AnalystCanaccord Genuity Wealth Management

Continue reading

Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights

– Product development focused on the production of powder formulations of oat beta glucan and avenanthramides for cosmeceuticals market – Technology development focused on the PGX pilot scale units – Q3 2023 sales of $2,619,000 vs $3,845,000 in Q3 2022; YTD sales of $7,983,000 vs $15,517,000 – Ended the quarter with $11.4 million in cash allowing funding for planned pipeline and technology developments EDMONTON, Alberta, Nov. 29, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the third quarter and nine months ended September 30, 2023. “While the base business has experienced...

Continue reading

Celestica To Hold Previously-Announced Virtual Investor Meeting Today

Company reaffirms 2023 annual financial outlook, raises 2024 non-IFRS adjusted earnings per share* outlook, and provides 2025 and 2026 financial targets TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) — Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, will hold a previously-announced virtual investor meeting today at 1:00pm ET. During the meeting, Celestica’s management will provide an overview of the business outlook and growth opportunities in the company’s Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS) segments, and details on its near-term financial outlook and long-term financial targets. Celestica’s management will reaffirm its 2023 annual financial outlook of: Revenue of $7.9 billion Non-IFRS...

Continue reading

Stantec Closes $288 Million Bought Deal Offering of Common Shares

EDMONTON, Alberta, Nov. 29, 2023 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec Inc. (the “Corporation” or “Stantec”), a global leader in sustainable design and engineering, is pleased to announce that it has closed its previously announced bought deal public offering of common shares (the “Offering”). Pursuant to the Offering, Stantec issued 3,108,450 common shares (the “Shares”) from treasury, including 405,450 Shares issued in connection with the exercise in full of the over-allotment option granted to the Underwriters (as defined below), at a price of $92.50 per Share, for total gross proceeds of $287,531,625. The Offering was completed through a syndicate of underwriters (collectively, the “Underwriters”), co-led by National Bank Financial Inc. and CIBC Capital Markets, acting as co-bookrunners. Stantec intends to use the net proceeds...

Continue reading

Proterra Receives Court Approval for Sale of Proterra Powered Business Line

Proterra Transit Business Line Hearing Date Scheduled for December 12, 2023 BURLINGAME, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) — Proterra Inc (OTC: PTRAQ) (“Proterra” or the “Company”), a leading innovator in commercial vehicle electrification technology, today announced that the Company has received final approval from the U.S. Bankruptcy Court for the sale of the Company’s Proterra Powered business line to Volvo Battery Solutions LLC (“Volvo”). Proterra Powered leverages the Company’s industry-leading battery technology and expertise to electrify commercial vehicles. The transaction close date is expected to occur in Q1 of 2024. The Sale hearing for Phoenix Motor, Inc.’s (“Phoenix”) pending acquisition of the Proterra Transit business line has been moved to December 12, 2023. Proterra Transit is a leading manufacturer of zero-emission,...

Continue reading

Alpha Tau to Participate in Sidoti Small-Cap Conference

JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will present at the Sidoti Small-Cap Virtual Conference on Thursday, December 7th, 2023. Format: Presentation and 1-on-1 meetings Date: December 7th, 2023 Time: 9:15 AM ET Location: Virtual Registration: https://sidoti.zoom.us/webinar/register/WN_VNDWwCEtSeySoAVKVx38YQ About Alpha Tau Medical, Ltd. Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from...

Continue reading

US Nuclear Corp. Announces Third Quarter 2023 Results

LOS ANGELES, CA, Nov. 29, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –US Nuclear Corp. (OTC-QB: UCLE), a leading manufacturer of advanced radiation, chemical, and biological detection and UAV instrumentation, recently announced the financial results for the third quarter ended September 30, 2023.   For the three months ended September 30, 2023: Sales were $593,502 compared to $617,434 for the same period in 2022 Cost of goods decreased by a factor of 3 compared to the same period in 2022, from 66% to only 22% Gross margins increased by 44.15% due to a mix of enhanced manufacturing efficiency and higher margin products sold during the period. The Company expects this trend to continue due to increased sales of US Nuclear’s premium highly valued, specialized products. Selling, general and administrative expenses were $539,339 compared...

Continue reading

Camposol Holding PLC reports its Third Quarter 2023 preliminary results.

Camposol Holding PLC sales amounted to USD 264.6 million, with a recorder gross profit margin of 27.9%, during the first nine months of 2023. EBITDA from continuing operations reached USD 52.3 million, up 32.7% compared to the same period in 2022, with a corresponding EBITDA margin was 19.7%. This increase is mainly explained by higher prices of blueberries. As of September 30th, 2023, the Company maintained a cash balance of USD 22.2 million and a net leverage ratio of 7.5x. The Company continues executing its strategy to become a year-round supplier of fresh fruit to our global clients complementing its Peruvian window operations with investments in Colombia, Uruguay and lately in Chile, and capitalizing on its commercial and logistic platforms. Please see the first quarter financial results’ report enclosed (or click on the link below...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.